Navigation Links
Scientists Identify the Most Significant Single Predictor of Aggressive Prostate Cancer

An elevated rate of increase in prostate specific antigen (PSA) levels is the most significant predictor of aggressive form of prostate cancer, according to a new study published in the journal Cancer.

The study suggests if the rate of PSA increase prior to treatment (PSA Velocity) is more than 2 ng/ml/year, it is an indication of a high risk of death from prostate cancer.

According to the researchers, the new findings attain significance with recent studies suggesting that factors like microscopic features of the tumour (Gleason score), and size, spread and location of the disease are not very effective to determine prognosis.

Dr. Anthony DAmico of Bostons Brigham and Womens Hospital and colleagues characterised PSA velocity significant in prostate cancer-specific mortality (PCSM) rates following treatment with radical prostatectomy (RP) or radiation therapy (RT).

The researchers reviewed data from 948 men with localized prostate cancer who had one or more high-risk factors, and found that PSA velocity appeared to be the most important single prognostic factor. They observed that men who had multiple risk factors died from their disease significantly earlier than those who had only one factor.

Among men who underwent treatment with RP or RT, 44 per cent and 28 per cent, respectively, had pre-treatment PSA velocities of 2 ng/ml/year as their only identified high-risk factor.

It was observed that of those men who died with only one identified high-risk factor, 88 per cent of RP-treated patients and 80 per cent of RT-treated patients had pre-treatment PSA velocities of 2 ng/ml/year.

The study authors have also pointed out at the results of various other studies that have shown that the time to death shortens as PSA velocity increases, which suggests that further research should examine using stratified PSA velocities to assess risk in men with localised disease.

"These findings hi ghlight the ability of a pre-treatment PSA velocity 2 ng/ml/year alone to identify men with aggressive prostate cancer and in whom effective systemic treatment in addition to mono-therapy with RP or RT is needed to decrease PCSM rates," conclude the authors.


'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2016)... ... ... a year and a half of planning the Multiple Pathways of Recovery Conference , ... Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel & ... explore the many pathways individuals use to get into and sustain their recovery. Pathways ...
(Date:5/27/2016)... Los Angeles, CA (PRWEB) , ... May 27, 2016 , ... ... Institutes of Health, so it is not surprising that bariatric surgery has received increased ... Baltimore Business Journal explains. Of course, when it comes to weight loss, most people ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross ... and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their ... Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... annual campaign returns for a third time to shed lights on the variety of ... resources and inspirational stories, “Nurse Appreciation” tackles why this career has gone from being ...
(Date:5/27/2016)... ... May 27, 2016 , ... This campaign aims to provide a ... as a society can control and change. , As nearly 795,000 Americans suffering from ... within the United States. Plus, with an estimated 129,000 of these people dying from ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 According ... of hypertension is driving ambulatory blood pressure monitoring system ... elasticity and their ability to respond to different pressure ... condition can lead to various cardiovascular disorders such as ... disease. These diseases are growing in prevalence each year. ...
(Date:5/26/2016)... , May 26, 2016 According to ... Waste Management Market - U.S. Industry Analysis, Size, Share, Growth, ... market in the U.S. was valued at US$ 5.89 Bn ... of 3.4% from 2015 to 2023 to reach US$ 7.99 ... of current and emerging needle free drug delivery devices and ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: